Synthesis, characterization, in-silico and in-vitro anticancer studies of Plumbagin encapsulated albumin nanoparticles for breast cancer treatment
Author:
Funder
Council of Scientific and Industrial Research, India
Central University of Gujarat
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference76 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021
2. Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer;More;Med. Drug. Discov.,2021
3. Multidrug-resistant breast cancer: current perspectives;Martin;Breast Cancer,2014
4. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery;Rouzier;J. Clin. Oncol.,2001
5. Plumbagin, a medicinal plant–derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer;Aziz;Cancer Res.,2008
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The phytochemical plumbagin: mechanism behind its “pleiotropic” nature and potential as an anticancer treatment;Archives of Toxicology;2024-09-13
2. Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review;Nutrients;2024-09-08
3. Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance;Drug Discovery Today;2024-08
4. Berberine encapsulated phenylboronic acid-conjugated pullulan nanoparticles: Synthesis, characterization and anticancer activity validated in A431 skin cancer cells and 3D spheroids;International Journal of Biological Macromolecules;2024-07
5. Effect of the Presence of Colloidal Gamma Globulin Nanocarrier for Sustained Carboplatin Release Enhancement: Preparation, Characterization, Drug Release and Efficacy Assessment;BioNanoScience;2024-06-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3